Advertisement
EuroPCR 2021 - Innovations in chronic heart failure
18 May 2021 – From EuroPCR 2021
This session will provide you with 90-day outcomes of a novel no-implant interatrial shunt first in human trial, six-month outcomes of transcatheter LV restoration in heart failure patients, and mid-term results of hybrid LV reconstruction in ischemic HFrEF.
